Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Tenofovir Disoproxil Fumarate since 2013?

What pharmacies pay, not what you pay. Tenofovir Disoproxil Fumarate has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Tenofovir Disoproxil Fumarate 300 MG Tablet: $1.41 per unit at the 2018 survey and $0.296 at 2026 (−79%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Tenofovir Disoproxil Fumarate1 product in NADAC
1product with a price history
  1. Tenofovir Disoproxil Fumarate has 1 product in the CMS NADAC survey, 1 product with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Tenofovir Disoproxil Fumarate 300 MG Tablet

Generic

$1.41 per unit at the 2018 year-end survey (10 NDCs) and $0.296 at the 2026 survey (12 NDCs): −79%.

$0$1.412018: median $1.41 per unit, 10 NDCs priced2019: median $0.995 per unit, 12 NDCs priced2020: median $0.949 per unit, 10 NDCs priced2021: median $0.663 per unit, 9 NDCs priced2022: median $0.520 per unit, 11 NDCs priced2023: median $0.455 per unit, 11 NDCs priced2024: median $0.420 per unit, 11 NDCs priced2025: median $0.347 per unit, 11 NDCs priced2026: median $0.296 per unit, 12 NDCs priced20182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2018 (2018-12-26)$1.4110
2019 (2019-12-25)$0.99512
2020 (2020-12-30)$0.94910
2021 (2021-12-29)$0.6639
2022 (2022-12-28)$0.52011
2023 (2023-12-27)$0.45511
2024 (2024-12-25)$0.42011
2025 (2025-12-31)$0.34711
2026 (2026-11-11)$0.29612

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Tenofovir Disoproxil Fumarate sit on the generic price cliff?

Tenofovir Disoproxil Fumarate 300 MG Tablet: the first generic approval in its Orange Book group is dated 2015. Its year-end acquisition cost in 2026 is 21% of its first observed year-end price (2018). The median matched product, 11 years after its first generic approval, is at 21% (the middle half runs from 5% to 51%), so this product is inside that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsTenofovir Disoproxil Fumarate 300 MG Tablet, 3 years after the first generic approval: 100% of its first observed price, 10 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 4 years after the first generic approval: 70% of its first observed price, 12 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 5 years after the first generic approval: 67% of its first observed price, 10 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 6 years after the first generic approval: 47% of its first observed price, 9 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 7 years after the first generic approval: 37% of its first observed price, 11 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 8 years after the first generic approval: 32% of its first observed price, 11 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 9 years after the first generic approval: 30% of its first observed price, 11 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 10 years after the first generic approval: 25% of its first observed price, 11 NDCs pricedTenofovir Disoproxil Fumarate 300 MG Tablet, 11 years after the first generic approval: 21% of its first observed price, 12 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productTenofovir Disoproxil Fumarate 300 MG Tablet

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

How many companies make Tenofovir Disoproxil Fumarate?

The FDA Orange Book lists 11 generic makers as marketed in its largest dosage form for Tenofovir Disoproxil Fumarate, and the first generic approval is dated 18 March 2015. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Tenofovir Disoproxil Fumarate on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).